Macro­Gen­ics los­es CMO Jon Wig­gin­ton as com­mer­cial­iza­tion looms

The next few months are im­por­tant for Macro­Gen­ics. They may soon have their first ap­proved drug. They could even de­feat moun­tain­ous odds and eclipse Keytru­da in a head to head tri­al.

But what­ev­er they do, they’ll do it with­out long­time CMO Jon Wig­gin­ton.

The can­cer biotech an­nounced yes­ter­day that af­ter 7 years, Wig­gin­ton will leave the com­pa­ny at the end of the month to pur­sue a new op­por­tu­ni­ty. CSO Ezio Bon­vi­ni will as­sume his role while Macro­Gen­ics search­es for a re­place­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER